Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-967-9 | CAS number: 7782-87-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
There were no acute toxicity for Potassium phosphinate however acute toxicity studies were available for Sodium phosphinate also named Sodium hypophosphite and can be used for read across as follows:
- an acute oral toxicity test in rats
(method comparable to EPA 870.1100 and OECD 401 guidelines, GLP
compliance not stated in the study report)
- an acute dermal toxicity test in rabbits (method comparable to EPA
870.1200 and OECD 402 guidelines, GLP compliance not stated in the study
report)
Sodium hypophosphite is of low acute toxicity following oral exposure:
The oral LD50 was found to be greater than 5000 mg/kg bw in male rats. The
oral LD50 in female rats was found to be lower than 5000 mg/kg bw and
should be included in the 2000-5000 mg/kg bw acute toxic class.
Sodium hypophosphite is of low acute toxicity following dermal exposure:
The dermal LD0 was determined to be equal or greater than 2000 mg/kg bw
in rabbits.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 1982-12-02 to 1982-12-22
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions. Methodology used is similar to OECD 401 and OPPTS 870.1100 (limit test) guidelines. No details on experimental conditions. Only raw data reported.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- Reliability scoring based on 2001 guideline for test n°401
- Deviations:
- no
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: in average 200 grams (for details see table 2 in free text of results and discussions)
- Housing: 5 rats of same sex/treatment per cage
- Diet: fasted
IN LIFE DATE: from 1982-12-08 to 1982-12-22 or from 1982-12-2 to 1982-12-16
No more data available - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): dose volumes were calculated from the fasting body weights of the rats and the selected dose volume was 10 ml/kg
body weight.
MAXIMUM DOSE VOLUME APPLIED: 10 mg/kg body weight. - Doses:
- 0, 2000 and 5000 mg/kg
- No. of animals per sex per dose:
- - 20 males and 10 females for the negative control (0 mg/kg; only water)
- 10 males for 2000 mg/kg,
- 10 males and 10 females for 5000 mg/kg - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: twice a day and weighing at 0, 7 and 14 days after exposure
- Necropsy of survivors performed: yes
No more data available - Statistics:
- None
- Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: limit test: no mortality
- Sex:
- female
- Dose descriptor:
- approximate LD50
- Effect level:
- <= 5 000 mg/kg bw
- Remarks on result:
- other: limit test: mortality 6/10
- Sex:
- male
- Dose descriptor:
- approximate LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- other: limit test: mortality 3/10
- Mortality:
- - At 2000 mg/kg , no deaths occurred in male rats.
- At 5000 mg/kg, 3 out of 10 males and 6 out 10 females died on day 2.
- In the negative control groups, no deaths occurred. - Clinical signs:
- - In males exposed to 2000 mg/kg, mild depression and piloerection were observed from day 1 (1 hour after dosing) to day 2.
- In males and females exposed to 5000 mg/kg, mild depression and piloerection were observed from day 1 (immediately after dosing) to day 3.
- There were no clinical signs in the negative control groups. - Body weight:
- Cf table 2 in free text of Results and discussions
- Gross pathology:
- - Red lungs and stomachs filled with a clear watery fluid were reported in the 3 males and 6 females found dead in the 5000 mg/kg bw groups.
- The remaining animals showed no macroscopic lesions at necropsy. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: other: CLP ( reg 1272/2008/EC)
- Conclusions:
- Sodium hypophosphite is not classified according to CLP (Reg. n° 1272/2008/EC).
- Executive summary:
The objective of this study was to evaluate the toxicity of Sodium Hypophosphite following a single oral administration in rats according to methods similar to OPPTS 870.1100 and OECD 401 guidelines. There were no information in the report about GLP compliance.
Sodium hypophosphite was prepared in water and was administered by gavage under a dosage-volume of 10 ml/kg bw to groups of 10 fasted rats.
Based on a previous study (not available) indicating that LD50 was greater than 1000 mg/kg in male rats, the first dose of the test item to be tested in male rats was 2000 mg/kg. The other tested dose-level administered was 5000 mg/kg (1 group of females, 1 group of males). Negative control groups receiving water only were included in the study.
Clinical signs, mortality and body weight were checked for a period of 14 days following the single administration of the test item. All animals were subjected to necropsy.
At the dose-level of 2000 mg/kg, no mortality occurred. Mild depression and piloerection were observed from day 1 (1 hour after dosing) to day 2. body weight gain was similar to controls and no apparent abnormalities were observed at necropsy
At the dose- level of 5000 mg/kg , 3 out 10 males and 6 out 10 females were found dead on day 2. At necropsy, red lungs and stomachs filled with a clear watery fluid were reported in those animals. In the surviving animals, mild depression and piloerection were observed from day 1 (immediately after dosing) to day 3. Body weight gain was similar to controls and no apparent abnormalities were observed at necropsy.
Under the experimental conditions of this study, the oral LD50 in male rats is higher than 5000 mg/kg and the oral LD50 in female rats should be included in the 2000 -5000 mg/kg bw acute toxic class.
Reference
Table 1: Summarized results for cumulative mortality
Acute oral toxicity, cumulative mortality | ||||||||||||
Day | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex |
0 | M | 0 | M | 0 | F | 2000 | M | 5000 | M | 5000 | F | |
Cumulative mortality | Cumulative mortality | Cumulative mortality | Cumulative mortality | Cumulative mortality | Cumulative mortality | |||||||
0 | 0/10 | 0/10 | 0/10 | 0/10 | 0/10 | 0/10 | ||||||
1 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
2 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
3 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
4 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
5 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
6 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
7 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
8 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
9 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
10 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
11 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
12 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
13 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 | ||||||
14 | 0/10 | 0/10 | 0/10 | 0/10 | 3/10 | 6/10 |
Table 2: Body weight summary
Acute oral toxicity, | ||||
Dose (mg/ kg) | Sex | Mean body weight (for 10 rats) in grams | ||
Day 0 | Day 7 | Day 14 | ||
0 | M | 203.5 | 277 | 319.5 |
0 | M | 204.3 | 288 | 329 |
2000 | M | 204 | 283.3 | 326 |
5000 | M | 205 | 272 | 317 |
0 | F | 168 | 200.8 | 206 |
5000 | F | 170 | 219 | 237 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Good; the study is compliant with Reach guidance requirements
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 1984-05-15 to 1984-05-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable guideline study with acceptable restrictions. Methodology used is similar to OECD guideline 402 and guideline OPPTS 870.1200 (limit test) with deviations (less than 5 animals tested). No details on experimental conditions. Only raw data reported.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- less than 5 animals tested with intact skin
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- Reliability scoring based on 1987 guideline for test n°402
- Deviations:
- yes
- Remarks:
- less than 5 animals tested with intact skin
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation:
Control rabbits mean weight: 2033 grams
Dosed rabbits mean weight: 1798 grams
For details: see table 2 in free text of results and discussions
IN-LIFE DATES: From: 1984-05-15 to 1984-05-29
No more data available - Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- TEST MATERIAL
- Amount(s) applied: 2000 mg/kg body weight
No more data available - Duration of exposure:
- 24 hours
- Doses:
- One dose at 2000 mg/kg (limit dose)
- No. of animals per sex per dose:
- - Negative controls: 2 males and 2 females with for each sex 1 with abraded skin and 1 with intact skin
- 2000 mg/kg bw: 5 males (3 of which with abraded skin ) and 5 females (2 of which with abraded skin) - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 0, 7 and 14 days after exposure
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology and behaviour - Statistics:
- No data
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Mortality:
- No deaths were observed during the study.
cf table 1 in results and discussions free text - Clinical signs:
No systemic clinic signs were observed during the study at the dose-levels of 2000 mg/kg. Moderate erythema and mild to moderate oedema were observed on removal of the dressing. These local reactions cleared within 24 hours.
There were no effects in the control group.- Body weight:
- cf table 2 in results and discussions free text
- Gross pathology:
- No abnormalities were observed at macroscopic examination.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: other: CLP (Reg. 1272/2008/EC)
- Conclusions:
- Sodium hypophosphite is not classified according to CLP (Reg. n° 1272/2008/EC).
- Executive summary:
The objective of this study was to evaluate the toxicity of Sodium hypophosphite following a single dermal application to rabbits
according to methods similar to OPPTS 870.1200 and OECD 402 guidelines. There were no information in the report about GLP compliance.
The test item was applied to the skin of one group of five males (3 with abraded and 2 with intact skin) and five females (2 with abraded and 3 with intact skin) at the dose-level of 2000 mg/kg bw. One group of 2 males and 2 females acts as a control group (1 male and 1 female with abraded skin, 1 male and 1 female with intact skin).The test site was then covered by dressing for 24 hours. Clinical signs, mortality and body weight gain were checked for a period of 14 days following the single application of the test item. All animals were subjected to necropsy.
Neither mortality nor systemic clinical signs were observed during the study. A moderate erythema and a mild to moderate oedema were observed on removal of the dressing and cleared within 24 hours. The body weight gain of the animals was not affected by treatment compared to controls. No apparent abnormalities were observed at necropsy in any animal.
Under these experimental conditions, the dermal LD0of Sodium hypophosphite was equal or higher than 2000 mg/kg in rabbits
.
Reference
Summarized results:
Table 1: Summarized results for combined sex of cumulative mortality
Acute dermal toxicity, 24h exposure, cumulative mortality | ||||
Day | Dose (mg/ kg) | Sex | Dose (mg/ kg) | Sex |
0 | M/F | 2000 | M/F | |
Cumulative mortality | Cumulative mortality | |||
0 | 0/4 | 0/10 | ||
1 | 0/4 | 0/10 | ||
2 | 0/4 | 0/10 | ||
3 | 0/4 | 0/10 | ||
4 | 0/4 | 0/10 | ||
5 | 0/4 | 0/10 | ||
6 | 0/4 | 0/10 | ||
7 | 0/4 | 0/10 | ||
8 | 0/4 | 0/10 | ||
9 | 0/4 | 0/10 | ||
10 | 0/4 | 0/10 | ||
11 | 0/4 | 0/10 | ||
12 | 0/4 | 0/10 | ||
13 | 0/4 | 0/10 | ||
14 | 0/4 | 0/10 |
Applicant's remark: 5 animals per sex have been tested. however some were tested on abraded skin. Therefore, the minimum number of tested animals is not achieved. The results show no mortality nor clinical signs whatever the sex and the abraded or intact skin. So, the deviation of the number of animals tested is considered as minor and the LD0 > 2000 mg/kg bw can be used for the classification
Table 2: Summarized results for body weight
Acute dermal toxicity, 24h exposure | |||||
Skin status | Dose (mg/ kg) | Sex | Mean body weight in grams | ||
Day 0 | Day 7 | Day 14 | |||
Intact | 0 | M | 1794 | 2050 | 2259 |
Abraded | 0 | M | 1714 | 2049 | 2338 |
Intact | 0 | F | 2352 | 2528 | 2756 |
Abraded | 0 | F | 2272 | 2456 | 2662 |
Intact | 2000 | M | 1789 | 1909 | 2163 |
Abraded | 2000 | M | 1846 | 2046 | 2275 |
Intact | 2000 | F | 1750 | 1946 | 2151 |
Abraded | 2000 | F | 1808 | 2033 | 2336 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Good; the study is compliant with Reach guidance requirements
Additional information
Data from Sodium phosphinate also named sodium hypophosphite :
Acute oral toxicity
One study is reported for this endpoint and was chosen as a key study.
The acute oral toxicity was performed using a methodology similar to EPA OPPTS 870.1100 and OECD 401guidelines.There were no information in the report about GLP compliance.
Sodium hypophosphite was administered at dose-levels of 2000 and 5000 mg/kg bw to male rats. Females rats received only the highest dose.
Negative control groups receiving water only were included in the study.
there were no deaths in the controls and in the 2000 mg/kg bw dosed group while 3 out of 10 males and 6 out of 10 females were found dead at the 5000 mg/kg bw dose. At necropsy, red lungs and stomachs filled with a clear watery fluid were reported in the animals found dead. In the treated surviving animals, mild depression and piloerection were observed from day 1 to day 2 and from day 1 to day 3 in the 2000 mg/kg bw and 5000 mg/kg bw dosed groups respectively . Body weight gain was similar to controls and no apparent abnormalities were observed at necropsy.
Under the experimental conditions of this study, the oral LD50 in male rats was higher than 5000 mg/kg and the oral LD50 in female rats should be included in the 2000 -5000 mg/kg bw acute toxic class.
Acute dermal toxicity
One study is reported for this endpoint and was chosen as a key study.
The acute dermal toxicity was performed using a methodology similar to EPA OPPTS 870.1200 and OECD 402 guidelines.There were no information in the report about GLP compliance.
Sodium hypophosphite was applied to the skin of five males and five females at the dose-level of 2000 mg/kg bw. One group of 2 males and 2 females acts as a control group.
Neither mortality nor systemic clinical signs were observed during the study. A moderate erythema and a mild to moderate oedema were observed on removal of the dressing and cleared within 24 hours. The body weight gain of the animals was not affected by treatment compared to controls. No apparent abnormalities were observed at necropsy in any animal.
Under these experimental conditions, the dermal LD0 of Sodium hypophosphite was equal or higher than 2000 mg/kg in rabbits
Justification for classification or non-classification
According to the criteria laid down in EU regulation (EC) n° 1272/2008/EC (CLP) and EU directive 67/548/EEC, Potassium phosphinate does not have to be classified for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.